MedTrace Logo

PARQuit Smoking Cessation Intervention for Adults With Serious Mental Illness

NCT03950427 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 131

Last updated 2025-08-01

No results posted yet for this study

Summary

This is a research study about a smoking cessation program tailored for adults with serious mental illness (SMI). The program uses a Videogame-based Physical (VIP) activity, smoking cessation counseling, and medication (bupropion),

Conditions

  • Smoking Cessation
  • Smoking, Tobacco
  • Mental Illness
  • Tobacco Use Disorder

Interventions

BEHAVIORAL

Videogame-based physical activity

videogame-based physical activity

BEHAVIORAL

Sedentary videogame

sedentary videogame

DRUG

Bupropion

Bupropion

BEHAVIORAL

Counseling

Counseling for smoking cessation

Sponsors & Collaborators

Principal Investigators

  • Heather Leutwyler, PhD · University of California, San Francisco

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-08
Primary Completion
2025-07-30
Completion
2025-07-30
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03950427 on ClinicalTrials.gov